# EDGAR Filing Document

**Accession Number:** 0001584371
**File Stem:** 0001213900-25-070666
**Filing Date:** 2025-8
**Character Count:** 8295
**Document Hash:** 25e4b758298370b74bacdbd724fc1181
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-070666.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001213900-25-070666

**CONFORMED SUBMISSION TYPE**: POS AM

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250801

**DATE AS OF CHANGE**: 20250801

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IceCure Medical Ltd.
- **CENTRAL INDEX KEY:** 0001584371
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** POS AM
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-288062
- **FILM NUMBER:** 251176855

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 7 HA'ESHEL ST., POB 3163
- **CITY:** CAESAREA
- **PROVINCE COUNTRY:** L3
- **ZIP:** 38900
- **BUSINESS PHONE:** 972-4-6230333

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 7 HA'ESHEL ST., POB 3163
- **CITY:** CAESAREA
- **PROVINCE COUNTRY:** L3
- **ZIP:** 38900

**As filed with the Securities and Exchange Commission on August 1, 2025**

**Registration No. 333-288062**

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**POST-EFFECTIVE AMENDMENT NO. 1**

**TO**

**FORM F-1**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

**ICECURE MEDICAL LTD.**

*(Exact name of registrant as specified in its charter)*

---

| | | |
|:---|:---|:---|
| **State of Israel** | **3841** | **Not Applicable** |
| *(State or other jurisdiction of*<br> *incorporation or organization)* | *(Primary Standard Industrial*<br> *Classification Code Number)* | *(I.R.S. Employer*<br> *Identification Number)* |

---

---

| | |
|:---|:---|
| **Eyal Shamir<br> Chief Executive Officer<br> 7 Ha'Eshel St., PO Box 3163<br> Caesarea, 3079504 Israel<br> Tel: +972.4.6230333** | **IceCure Medical Inc.<br> 10 W Prospect Street, Suite 401<br> Nanuet, New York 10954<br> Tel: +1.888.902.5716** |
| *(Address, including zip code, and telephone number,* | *(Name, address, including zip code, and telephone* |
| *including area code, of registrant's principal executive offices)* | *number, including area code, of agent for service)* |

---

***Copies to:***

 

---

| | | |
|:---|:---|:---|
| **Oded Har-Even, Esq.<br> Eric Victorson, Esq. <br> Sullivan & Worcester LLP** <br> **1251 Avenue of the Americas <br> New York, New York 10020** <br> **Tel: 212.660.3000** | **Reut Alfiah, Adv.** <br> **Gal Cohen, Adv.** <br> **Sullivan & Worcester Tel-Aviv<br> (Har-Even & Co.)** <br> **HaArba'a Towers** <br> **28 HaArba'a St.** <br> **North Tower, 35<sup>th</sup> Floor** <br> **Tel-Aviv, Israel 6473925 <br> Tel: +972.74.758.0480** | **Faith L. Charles, Esq.<br> Thompson Hine LLP** <br> **300 Madison Avenue, 27<sup>th</sup> Floor<br> New York, New York 10017<br> Tel: 212.344.5680** |

---

**Approximate date of commencement of proposed sale to the public:** Not applicable.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ☒

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards † provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

&nbsp;&nbsp;&nbsp;&nbsp;† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

**This filing constitutes a Post-Effective Amendment to the Registration Statement on Form F-1 (File No. 333-288062), which was initially declared effective on July 9, 2025. This Post-Effective Amendment shall hereafter become effective in accordance with Section 8(c) of the Securities Act of 1933, as amended (the "Securities Act"), on such date as the Securities and Exchange Commission, acting pursuant to Section 8(c) of the Securities Act, may determine.** 

**EXPLANATORY NOTE**

**DEREGISTRATION OF UNSOLD SECURITIES**

On June 16, 2025, IceCure Medical Ltd., or the Company, filed a registration statement on [Form F-1](https://www.sec.gov/Archives/edgar/data/1584371/000121390025054497/ea0244924-f1_icecure.htm) (File No. 333-288062), as amended, or the Registration Statement, with respect to the registration of 10,000,000 units, or the Units, each whole Unit consisting of (a) one ordinary share, no par value, or Ordinary Share, and a warrant to purchase one Ordinary Share, or Warrant, or (b) one pre-funded warrant to purchase one Ordinary Share, or Pre-Funded Warrant, and a Warrant to purchase one Ordinary Share to holders of the Company's Ordinary Shares owned as of the record date at 5:00 p.m., Eastern Time, on July 9, 2025. The Registration Statement registered 10,000,000 Ordinary Shares, or Pre-Funded Warrants in lieu thereof, and Warrants to purchase up to an additional 10,000,000 Ordinary Shares. The Registration Statement was declared effective on July 9, 2025. As reported in its Report of Foreign Private Issuer on Form 6-K filed August 1, 2025, subscription rights for an aggregate of 9,999,994 Units were validly subscribed for by holders of such subscription rights, resulting in the issuance of 9,954,756 Ordinary Shares, Warrants to purchase up to 9,999,994 Ordinary Shares and Pre-Funded Warrants to purchase up to 45,238 Ordinary Shares.

In accordance with the undertakings made by the Company in the Registration Statement to remove from registration, by means of post-effective amendment, any of the securities remaining unsold at the termination of the offering, the Company hereby removes from the Registration Statement six Units, consisting of six Ordinary Shares and Warrants to purchase up to six Ordinary Shares, together with such indeterminate number of Ordinary Shares as may have become issuable upon exercise of the Warrants registered pursuant to Rule 416 under the Securities Act of 1933, as amended, that were registered but unsold.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement on Form F-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in Caesarea, Israel, on August 1, 2025.

---

| | |
|:---|:---|
| **ICECURE MEDICAL LTD.** | **ICECURE MEDICAL LTD.** |
| By: | /s/ Eyal Shamir |
|  | Eyal Shamir |
|  | Chief Executive Officer |

---

**AUTHORIZED REPRESENTATIVE IN THE UNITED STATES**

Pursuant to the Securities Act of 1933, as amended, the undersigned, IceCure Medical Inc., the duly authorized representative in the United States of IceCure Medical Ltd., has signed this registration statement on August 1, 2025.

---

| |
|:---|
| /s/ IceCure Medical Inc. |
| IceCure Medical Inc. |

---

No other person is required to sign this Post-Effective Amendment No. 1 to Form F-1 Registration Statement in reliance on Rule 478 under the Securities Act of 1933.